S025 Dermatologic Surgery Pearls: Optimizing Safety, Satisfaction, Efficiency
DESCRIPTION
This session will recognize opportunities to enhance the overall dermatologic surgery practice by highlighting pearls to improve patient safety and satisfaction. Discussions will also focus on physician safety and tips on optimizing efficiency in the surgical setting.
LEARNING OBJECTIVES
Discuss pearls to optimize patient and physician safety while maximizing efficiency in the dermatologic surgery clinical practice.
Discuss strategies to improve patient experience and satisfaction.
SCHEDULE
9:00 AM
Nail Surgery Tips
Kimberly Marie Ken, MD, FAAD
9:16 AM
Managing Complications
Ramin Fathi, MD, FAAD
9:32 AM
Skin Cancer Diagnostic Conundrums
Valencia D. Thomas, MD, FAAD
9:48 AM
Q&A
10:00 AM
Photography/Biopsy site identification
Kishwer S. Nehal, MD, FAAD
10:16 AM
Technology tools
David R. Carr, MD, MPH, FAAD
10:32 AM
Surgical Revision Pearls
Teo Soleymani, MD
10:48 AM
Q&A
11:00 AM
Improving Wellness and Health
Emily Clara Newsom, MD, FAAD
11:16 AM
Reducing risk of surgical injuries
Rachel Rigo, MD, FAAD
11:32 AM
Ergonomics in your practice
Patrick K. Lee, MD, FAAD
11:48 AM
Q&A
DIRECTOR
Kishwer S. Nehal, MD, FAAD
SPEAKERS
David R. Carr, MD, MPH, FAAD
Ramin Fathi, MD, FAAD
Kimberly Marie Ken, MD, FAAD
Patrick K. Lee, MD, FAAD
Emily Clara Newsom, MD, FAAD
Rachel Rigo, MD, FAAD
Teo Soleymani, MD
Valencia D. Thomas, MD, FAAD
DISCLOSURES
David R. Carr, MD, MPH, FAAD
Regeneron – Investigator(No Compensation Received);
Ramin Fathi, MD, FAAD
No financial relationships exist with ineligible companies.
Kimberly Marie Ken, MD, FAAD
No financial relationships exist with ineligible companies.
Patrick K. Lee, MD, FAAD
No financial relationships exist with ineligible companies.
Kishwer S. Nehal, MD, FAAD
No financial relationships exist with ineligible companies.
Emily Clara Newsom, MD, FAAD
No financial relationships exist with ineligible companies.
Rachel Rigo, MD, FAAD
No financial relationships exist with ineligible companies.
Teo Soleymani, MD
No financial relationships exist with ineligible companies.
Valencia D. Thomas, MD, FAAD
Castle Biosciences, Inc – Advisory Board(Honoraria); Merk – Advisory Board(Honoraria); National Comprehensive Cancer Network – Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria);